key: cord-0988802-l6m4ovq2 authors: Charre, Caroline; Ginevra, Christophe; Sabatier, Marina; Regue, Hadrien; Destras, Grégory; Brun, Solenne; Burfin, Gwendolyne; Scholtes, Caroline; Morfin, Florence; Valette, Martine; Lina, Bruno; Bal, Antonin; Josset, Laurence title: Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation date: 2020-10-05 journal: Virus Evol DOI: 10.1093/ve/veaa075 sha: ec5b9b0cd1df7416e21be2ac6895e9ba720b488c doc_id: 988802 cord_uid: l6m4ovq2 Since the beginning of the COVID-19 outbreak, SARS-CoV-2 whole-genome sequencing (WGS) has been performed at unprecedented rate worldwide with the use of very diverse Next Generation Sequencing (NGS) methods. Herein, we compare the performance of four NGS-based approaches for SARS-CoV-2 WGS. Twenty four clinical respiratory samples with a large scale of Ct values (from 10.7 to 33.9) were sequenced with four methods. Three used Illumina sequencing: an in-house metagenomic NGS (mNGS) protocol and two newly commercialized kits including a hybridization capture method developed by Illumina (DNA Prep with Enrichment kit and Respiratory Virus Oligo Panel, RVOP) and an amplicon sequencing method developed by Paragon Genomics (CleanPlex SARS-CoV-2 kit). We also evaluated the widely used amplicon sequencing protocol developed by ARTIC Network and combined with Oxford Nanopore Technologies (ONT) sequencing. All four methods yielded near-complete genomes (>99%) for high viral loads samples (n = 8), with mNGS and RVOP producing the most complete genomes. For mid viral loads (Ct 20-25), amplicon-based enrichment methods led to genome coverage >99% for all samples while 1/8 sample sequenced with RVOP and 2/8 samples sequenced with mNGS had a genome coverage below 99%. For low viral loads (Ct ≥ 25), amplicon-based enrichment methods were the most sensitive techniques. All methods were highly concordant in terms of identity in complete consensus sequence. Just one mismatch in three samples was observed in CleanPlex vs the other methods, due to the dedicated bioinformatics pipeline setting a high threshold to call SNP compared to reference sequence. Importantly, all methods correctly identified a newly observed 34-nt deletion in ORF6 but required specific bioinformatic validation for RVOP. Finally, as a major warning for targeted techniques, a loss of coverage in any given region of the genome should alert to a potential rearrangement or a SNP in primer annealing or probe-hybridizing regions and would require further validation using unbiased metagenomic sequencing. A novel human betacoronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in China in December 2019, rapidly spreading worldwide and resulting in the coronavirus disease 2019 (COVID-19) pandemic . Whole-genome sequencing (WGS) of SARS-CoV-2 has played a major role since the onset of the pandemic. Notably WGS has contributed to design specific RT-PCRs (Corman et al., 2020) , antiviral strategies (Dai et al., 2020) , and vaccine candidates (Kames et al., 2020) . SARS-CoV-2 WGS also allowed to explore lineage transmission and might be useful to assess the effectiveness of intervention measures (Consortium et al., 2020; Grubaugh et al., 2019; Oude Munnink et al., 2020 ; "Preliminary analysis of SARS-CoV-2 importation & establishment of UK transmission lineages," 2020). Furthermore SARS-CoV-2 genomic surveillance allowed the characterization of some substitutions for which the impact on virulence and transmissibility needs to be confirmed Batty et al., 2020a; Holland et al., 2020) . SARS-CoV-2 WGS is performed at an unprecedented rate worldwide with the use of very diverse Next Generation Sequencing (NGS) methods. Viral metagenomic NGS (mNGS) enabled early sequencing of the SARS-CoV-2 genome and is the method routinely used in the French National Reference Centre for Respiratory Viruses (NRC, Lyon, France). However, this method lacks sensitivity and cannot produce whole genomes for low viral load samples, except using a very high depth of sequencing . Targeted methods such as amplicon-or capture-based enrichments are promising candidates to overcome this issue. We proposed herein a formal comparative study of these different approaches to complete and enrich the sparse data already available . Herein, we aimed to assess performance of four NGS-based approaches for SARS-CoV-2 WGS. Three used Illumina sequencing: an in-house metagenomic NGS (mNGS) protocol and two newly commercialized kits including a hybridization capture method developed by Illumina (RVOP) 4 and an amplicon sequencing method developed by Paragon Genomics (CleanPlex). We also assessed a widely used amplicon sequencing protocol developed by the ARTIC network and combined with Oxford Nanopore Technologies (ONT) sequencing (Consortium et al., 2020; "https://artic.network/ncov-2019," n.d.) . The present evaluation covers experimental process as well as the associated bioinformatic solutions recommended for each technique. Importantly, this evaluation included two samples with a newly observed 34-nt deletion in ORF6 (Quéromès et al., 2020) in order to assess the capacity to detect large modification in SARS-CoV-2 genome. A total of 24 clinical samples (nasopharyngeal swab) with a broad range of representative SARS-CoV-2 cycle threshold (Ct) values (from 10.7 to 33.9) were selected for sequencing. We defined 3 groups of samples: a low Ct values group (Ct<20), a medium Ct values group (20≤Ct<25) and high Ct values group (Ct≥25). Each sample was tested with a multiplexed real time reverse-transcriptase polymerase chain reactions (RT-PCR) targeting distinct RdRp gene regions namely IP4 and IP2 (Institut Pasteur assay, Paris, France ("Molecular assays to diagnose " n.d.) ). In the present study, Ct values are those of the most sensitive target (IP4). Detailed of the Ct values for each sample are presented in the Supplementary Illumina sequencing DNase treatment (Life Technologies, Carlsbad, CA, USA) was performed after nucleic acid extraction in order to increase sensitivity of RNA virus detection and overcome human contamination (Bal et al., 2018) . Nucleic acids were randomly amplified using the WTA2 kit (WTA2, Sigma-Aldrich, Darmstadt, Germany) and libraries were prepared using the Illumina Nextera XT kit (Illumina, San Diego, CA, USA). This in-house approach is routinely used to perform WGS SARS-CoV-2 genomic surveillance at the NRC Danesh et al., 2020; Quéromès et al., 2020) for samples with a Ct value <20. Hybrid capture-based approach was performed using the Illumina DNA Prep with Enrichment kit and Illumina Respiratory Virus Oligo Panel (RVOP) V1.0. First, 15µL of total nucleic acid were pretreated with DNase following the same protocol as for mNGS (RNA concentration range from about 2 to 50ng/µL, 4 samples below quantification limit). Then, double stranded cDNA synthesis was performed using 5µL of DNase pretreated RNA using the NEBNext ® mNGS data were analysed with an in-house pipeline. Briefly, low quality (